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Abstract: The current study demonstrates the first surface
modification for poly(dimethylsiloxane) (PDMS) microflui-
dic networks that displays a long shelf life as well as
extended hemocompatibility. Uncoated PDMS microchan-
nel networks rapidly adsorb high levels of fibrinogen in
blood contacting applications. Fibrinogen adsorption ini-
tiates platelet activation, and causes a rapid increase in
pressure across microchannel networks, rendering them
useless for long term applications. Here, we describe the
modification of sealed PDMS microchannels using an oxy-
gen plasma pretreatment and poly(ethylene glycol) grafting
approach. We present results regarding the testing of the
coated microchannels after extended periods of aging and
blood exposure. Our PEG-grafted channels showed signifi-
cantly reduced fibrinogen adsorption and platelet adhesion
up to 28 days after application, highlighting the stability
and functionality of the coating over time. Our coated
microchannel networks also displayed a significant reduc-
tion in the coagulation response under whole blood flow.
Further, pressure across coated microchannel networks
took over 16 times longer to double than the uncoated con-
trols. Collectively, our data implies the potential for a coat-
ing platform for microfluidic devices in many blood-
contacting applications. VC 2014 Wiley Periodicals, Inc. J Biomed
Mater Res Part A: 102A: 4195–4205, 2014.
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INTRODUCTION
Poly(dimethylsiloxane) (PDMS) elastomers have found a
broad range of biological applications due to a unique
combination of physical properties.1 Such properties
include: ﬂexibility, mechanical durability, optical transpar-
ency, chemical inertness, nontoxicity, and high gas perme-
ability, as well as ease of microfabrication.2,3 PDMS may be
most recognized for its contribution to several leading bio-
medical devices including breast implants, pacemaker
leads, catheters, shunts, and extracorporeal device mem-
branes.4 However, the unique properties of PDMS have
also made it versatile for application as a construction
material for microﬂuidic devices, especially for biological
applications.1 Microﬂuidic devices composed (at least in
part) of PDMS have been used for biomolecule separation,
immunoassays, cell culture, and artiﬁcial lungs.3,5–10
Despite the many advantages of PDMS, the natural hydro-
phobicity presents problems when used as a blood-
contacting surface.
It is well known that hydrophobic surfaces tend to adsorb
high levels of plasma proteins, leading to increased platelet
activation, and the intrinsic coagulation response.11–13 Although
protein adsorption is less of a problem on PDMS surfaces than
with other biomedical polymers, the level of foreign body
response remains high enough to cause thrombogenesis.14
Thrombogenic activity is particularly relevant for devices with
microscale features. Platelet aggregation and clotting can rap-
idly block microscale features and lead to decreased function
and device failure. To date, there have been very few studies
which report surface modiﬁcations of PDMS within an intact
microchannel structure that focus on hemocompatiblity testing
of the channel.14–16 Of these, none have tested long-term hemo-
compatibility (>1 h blood exposure).
Increasing the hydrophilicity of a material is one of the
most common approaches to reducing the initial biological
response of nonspeciﬁc protein adsorption and subsequent
cellular events.17 Well-hydrated surfaces tend to repel protein
binding through the combination of steric repulsion and the
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formation of a structured water layer.18,19 To impart hydro-
philicity and other material or biological properties, research-
ers have used a variety of strategies to modify the PDMS
surface.3,20 One of the most common methods is plasma
treatment, where hydroxyl or other functional groups are
generated on the PDMS surface by a reactive ionized gas.
Oxygen plasma treatments are able to apply a dense, conﬂu-
ent covering of hydroxyl (AOH) functional groups derived
from the reacting gas within a short reaction time. The major
drawback of this approach is the rapid hydrophobic recovery
of the PDMS, as uncured oligomers migrate from the material
bulk and rearrange the functional groups away from the
material surface.21,22 To avoid this problem, some modiﬁca-
tion methods gaining popularity strive to combine multiple
strategies, such as the pretreatment of PDMS with plasma or
UV energy to introduce reactive groups followed by the appli-
cation of a polyelectrolyte multilayer or functional molecule
to create a more stable, covalently bound surface.23–27 Specif-
ically, a number of groups have described the reaction of
methoxy-silane or other alkoxy-silane functional molecules
with plasma-treated PDMS surfaces to form a grafted silane
coating (Fig. 1).25,28–30 Our work also utilizes this silanization
reaction scheme in the context of an enclosed microchannel.
Most studies describing PDMS surface modiﬁcation, par-
ticularly those utilizing plasma pretreatment, have developed
and characterized their modiﬁcation methods on planar
material samples without microchannel geometries.23,27,31
The assembly of PDMS devices typically requires the expo-
sure of the inner channel surfaces to an additional plasma
step to enable bonding. Therefore, coatings that have been
applied before assembly may be destroyed by the reactive
plasma.32 Initial efforts have demonstrated the utility of
microchannel-based coatings to optimize properties such as
surface contact angle and electro-osmotic ﬂow for protein
separation applications.25,26,33,34 Other groups have tested
nonplasma based or nonsilanized coating methods both in
microchannels and on planar PDMS surfaces in the context of
developing protein resistant and blood contacting materi-
als.18,35–38 To date however, no study has described the
plasma pretreatment-based silanized coating of intact PDMS
microchannels and the long-term hemocompatibility testing
of those channels.
In the current work, we describe a method to apply a
siloxane-bound poly(ethylene glycol) (PEG) coating to an arbi-
trary, enclosed microchannel network (bed) after assembly. Sin-
gle microchannels were coated and characterized using contact
angle and XPS analyses. These microchannels were then eval-
uated for stability and basic functionality through physiologic
exposure to ﬁbrinogen solutions, platelet-rich plasma (PRP),
and whole blood. More complex, branching microchannel net-
works were coated and exposed to whole blood as a more
robust measure of long-term hemocompatibility.
MATERIALS AND METHODS
Materials
SU-8 2035 permanent epoxy negative photoresist and SU-8
developer were purchased from MicroChem (Newton, MA),
while 2-isopropanol was obtained from Sigma Aldrich (St.
Louis, MO). Glutaraldehyde solution, ethanol, and hexame-
thyldisilazane (HMDS) were also purchased from Sigma
Aldrich. Sylgard 184 silicone elastomer base and curing
agent were purchased from Dow Corning (Midland, MI). 2-
[methoxy(polyethyleneoxy)propyl]trimethoxysilane (PEG-sil-
ane), tech-90, 6–9 C2H4O groups was obtained from Gelest
(Morrisville, PA). Acetone, 99.8%, extra dry was purchased
from Acros Organics (Geel, Belgium). Dulbecco’s phosphate-
buffered saline (PBS) and Calcein AM dye were purchased
from Life Technologies (Grand Island, NY). Fluorescein
isothiocyanate-labeled human ﬁbrinogen (FITC-Fg) was
obtained from Molecular Innovations (Novi, MI). Heparin
sodium injection USP (1,000 USP units/mL) was obtained
from Hospira (Lake Forest, IL).
Microfabrication of PDMS microchannels
To create a pattern for the PDMS microchannel structures, a
mold was made on a 4 inch silicon wafer using soft lithogra-
phy microfabrication techniques.39 A layer of SU-8 photore-
sist was spin coated onto the silicon wafer using a Laurell
Technologies WS-650S-6NPP/LITE spin coater (North Wales,
PA), with the thickness corresponding to the height of the
casted channels. Transparency masks were printed using an
FIGURE 1. Schematic of the silanization reaction between a methoxy-
silane molecule and an oxygen plasma treated PDMS surface. In this
work, a PEG-functional silane is used.
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inkjet printer with the channel length and width features
and a Kinsten KVB-30D UV exposure unit (Australia) was
used to crosslink and pattern the photoresist. The same
methodology was used to create molds for a single micro-
channel with a height of 100 lm (length and width of 5 3
1 cm) and a branching microchannel network, with varying
channel heights of 225, 60, and 20 lm as well as varying
lengths and widths. The branching microchannel network
consists of a ﬂow path in which ﬂuid enters the tallest
channels, branches off two times into many smaller micro-
channels (60 and then 20 lm tall), and then exits the net-
work in the opposite way by condensing from many small
channels into the largest ones. This conﬁguration allows for
the applied surface coating to be tested in many different
microﬂuidic geometries simultaneously.
Sylgard 184 base polymer was thoroughly mixed with
curing agent at 10:1 w/w and degassed in a vacuum
desiccator for 1 h. The mixture was then poured over the
prepatterned silicon wafers and cured at 80C for 1 h. Addi-
tionally, polymer mixture was poured into an empty poly-
styrene dish to form a ﬂat top covering for the channels.
The cured polymer was then peeled from the molds, allow-
ing individual channels or microchannel beds and corre-
sponding top sections to be cut out (Fig. 2). Holes were
punched at both ends of the channel tops, and short sec-
tions of silicone tubing were bonded to the holes to allow
for ﬂuidic access.
Assembly and application of PEG coating
To assemble the single microchannel structure or complex
microchannel bed, one channel bottom and a ﬂat top section
were placed in a Nordson MARCH PX-250 Plasma Cleaning
System (Concord, CA) powered by an MKS ACG-3B RF Plasma
Generator (Andover, MA). The two channel components were
exposed to oxygen plasma under vacuum (900 mTorr O2,
25 W, 25 s).40 The activated surfaces were then brought into
contact and bonded to form an irreversibly sealed microchan-
nel with connected tubing ports at either end. A 50% (v/v)
PEG solution was made by diluting 0.5 mL PEG-silane in 0.5
mL acetone. After bonding, the channel was immediately ﬁlled
with the PEG solution and allowed to react for 1 h at room
temperature (Fig. 1). The channel was then thoroughly washed
with deionized water, cleared with air, and stored in an ambi-
ent environment until use. Uncoated control channels were
assembled using the same process without exposure to a PEG-
silane solution. These uncoated channels were stored for at
least 6 days before use to allow for the complete hydrophobic
recovery of the inner channel surfaces.25 Coated single micro-
channels were used to validate the application, stability, and
basic functionality of the coating. The branching microchannel
beds were then used to more rigorously test the long-term
performance of the coating under whole blood ﬂow.
Contact angle measurement
The contact angle of single microchannel surfaces was meas-
ured using the sessile drop method on a custom-built goniom-
eter (deionized water, 8 mL drop size). Images of the water
droplets were taken with a Tucsen TCA 1.31C camera (Fujian,
China) and the droplet angles were later measured using a
custom Matlab program. Four material samples for each group
were initially fabricated and remeasured at each time point
throughout the study. The contact angle was measured on at
least three different locations on each sample and averaged.
X-ray photoelectron spectroscopy (XPS)
Uncoated PDMS and PEG-coated material samples from sin-
gle microchannels were analyzed for elemental composition
using a PHI VersaProbe XPS Microprobe (Chanhassen, MN)
at the Swagelok Center for Surface Analysis of Materials,
Case Western Reserve University. Each sample was scanned
using a 15 incident angle, averaging the signal over a
0.3 3 0.7 mm area (300 mm ion beam size). Survey scans
were performed over 0–1,100 eV with a pass energy of
93.90 eV, while high resolution C1s scans used a 23.50 eV
pass energy. Elemental binding energies were referenced to
the Si2p binding energy of silicone at 102.0 eV.41
Protein adsorption study
To equilibrate the material surfaces to an aqueous environ-
ment, PEG-coated and uncoated single microchannels were
ﬁlled with PBS for 30 min at room temperature and then
FIGURE 2. Unassembled single PDMS microchannel (A) and branch-
ing microchannel network (B). The single microchannel (A) was used
in XPS studies, to test coating hydrophilicity over time, to measure
protein adsorption after extended periods of aging, and to determine
platelet adhesion. The complex microchannel network (B) was used
to test long term hemocompatibility under flow with whole blood.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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emptied immediately prior to the experiment. FITC-labeled
human ﬁbrinogen was diluted to a ﬁnal concentration of 0.5
or 2.0 mg/mL in PBS and warmed to 37C in a water bath.
The protein concentrations were chosen for physiological
relevance, with 2.0 mg/mL being approximately the level of
ﬁbrinogen found in normal human blood.42 This solution
was then pumped through either a PEG-coated or uncoated
control channel at 0.7 mL/min. using a Cole Parmer Master-
ﬂex L/S 7550 peristaltic pump (Vernon Hills, IL) for 1 h.
This ﬂow rate resulted in a wall shear stress of 5 dynes/
cm2 within the channels, mimicking the shear experienced
by the pulmonary vessels.43 PEG channels were stored in an
ambient environment after coating for various periods
before testing, either 0, 5, 10, 14, 21, or 28 days (three sep-
arate channels per time point). The 2 mg/mL experiment at
time point 0 was also repeated using an extended protein
exposure time of 8 h. Following protein ﬂow, the channel
was washed brieﬂy with PBS at the same ﬂow rate and
cut apart to allow for analysis of the inner protein-
exposed surfaces.
For ﬂuorescence measurement, 5 mm-diameter circular
samples of both channel surfaces (at least 8 samples/chan-
nel) were punched out and placed in a 96-well plate. The
ﬂuorescent signal was then measured using a Molecular
Devices SpectraMax M2e spectrophotometer (Sunnyvale,
CA). To estimate the adsorbed protein mass on the material
samples, a serial dilution of FITC-Fg in solution was pre-
pared and measured for ﬂuorescent intensity, creating a
standard curve.
Platelet and blood cell adhesion study
Freshly drawn human blood was obtained from consenting,
aspirin-refraining donors according to IRB protocol and
treated with sodium citrate at 10:1 (v/v) to prevent short-
term coagulation. The whole blood was then centrifuged to
separate PRP from the white and red blood cell layers. After
removal from the cell layers, calcein AM dye was added to
half of the PRP volume according to the manufacturer’s
instructions to ﬂuorescently label the platelets. The remain-
ing PRP volume was left unlabeled to be used for platelet
resuspension. Following calcein staining, all PRP was centri-
fuged a second time to collect the labeled platelets in a pel-
let. The ﬂuorescent platelets were then resuspended in
clean platelet-poor plasma, resulting in a volume of calcein-
stained PRP with minimal background ﬂuorescence. An
additional volume of nonseparated, nonstained whole blood
was also set aside for a separate experiment.
As in the protein adsorption study, the microchannel in
single microchannel devices was equilibrated with PBS for
30 min at room temperature and then emptied immediately
prior to the experiment. The stained PRP was warmed to
37C in a water bath and pumped through either a PEG-
coated (0 days storage) or uncoated control channel at 0.7
mL/min for 30 min. The channels were then washed brieﬂy
with PBS at the same ﬂow rate and cleared with air. The
washed channels were immediately imaged using a Zeiss
Observer D.1 ﬂuorescence microscope and AxioCam
MRm camera (Oberkochen, Germany) with a FITC ﬁlter
at 103 magniﬁcation. At least 16 images per channel were
taken, covering the entire channel length and including both
the center and edge regions. The images were analyzed using
a custom Matlab program, measuring the total ﬂuorescent
area per image and averaging the values across all images.
In a separate experiment, the unstained whole blood
was ﬂowed through uncoated and PEG-coated microchan-
nels using the protocol described above. Following washing,
these microchannels were cut apart and the inner surfaces
were prepared for SEM imaging. The material samples were
ﬁrst immersed in a 2.5% glutaraldehyde solution in PBS,
allowing the adhered cells to ﬁx overnight at 4C. After
washing with deionized water, the samples were dehydrated
in a deionized water/ethanol gradient of 50, 70, 95, and
100% ethanol for 15 min each. Finally, the surfaces were
covered with hexamethyldisilazane twice for 15 min and
allowed to air dry in a fume hood. The samples were then
mounted on SEM stubs and sputter coated with 5 nm of
palladium. Images of each channel surface were collected at
3.0 kV using a FEI Nova NanoLab 200 FEG-SEM/FIB scan-
ning electron microscope (Hillsboro, OR) at the Swagelok
Center for Surface Analysis of Materials, Case Western
Reserve University.
Blood ﬂow through complex microchannel networks
Freshly drawn whole porcine blood was obtained from
donor animals according to IACUC protocol and treated
with a clinically relevant level of heparin (6.7 U/mL). Prior
to the experiment, the ﬂow loop tubing and devices with
branching microchannel networks were primed with PBS at
room temperature to aid in the complete and even ﬁlling of
the channels with blood. Forty micrometer Pall blood trans-
fusion ﬁlters (Port Washington, NY) were connected to the
ﬂow circuit upstream of the microchannel beds to remove
any clots that may form due to contact with the blood res-
ervoir or circuit tubing. The blood was heated to 37C in a
water bath and pumped through either a PEG-coated (1 day
storage) or uncoated control microchannel bed at 0.7 mL/
min, recirculating to the blood reservoir in a closed loop.
The blood reservoirs were periodically stirred to prevent
settling of the blood and maintain even blood mixing. The
pressure drop across the microchannel beds and blood ﬁl-
ters was monitored throughout the experiment using Hon-
eywell 26PCCFA6D pressure sensors (Golden Valley, MN).
Pressure measurements were taken across the networks
every 2 min for the ﬁrst 30 min, every 5 min from 30 to 60
min, every 10 min from 1 to 2 h, and every 15 min from 2
to 7 h. If the networks were left overnight after 7 h, meas-
urements were automatically taken every minute. The pres-
sure sensors were powered using an Agilent E3620A Dual
Output DC Power Supply (Santa Clara, CA) and the voltage
signal recorded through a Keithley 2000 Multimeter (Cleve-
land, OH). The multimeter was computer-controlled via an
IEEE-488 GPIB connection, and the digital signal was con-
verted to pressure values using a custom Visual Basic pro-
gram. The experiment was continued for each microchannel
bed at least until the initial pressure drop doubled in mag-
nitude, where a doubling in pressure was deﬁned as the
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lifetime or the time until failure of the bed. In cases where
a microchannel bed lasted longer than 7 h, the experiment
was continued overnight to 19 h and the time at which the
pressure had doubled was determined from the dataset.
The initial pressure drop was deﬁned as the average of the
ﬁrst three pressure measurements obtained for a given bed.
Immediately after ending an experiment, the networks were
ﬂushed with PBS for 20 min at 0.7 mL/min and imaged to
qualitatively observe surface bound clots.
Statistics
Three single microchannels or four microchannel beds for
both the PEG-coated and uncoated groups were tested for
each experiment. On each single microchannel, at least three
measurements for contact angle, protein adsorption, and
platelet adhesion were made and averaged. For microchan-
nel beds, each 0–7 h pressure time point is the average of
30–50 measurements taken over a 5 s window. Time points
after 7 h are the average of 10 measurements over a 10
min window. Results were analyzed in Excel using a stu-
dent’s t-test and ANOVA. Plotted data for contact angle, pro-
tein adsorption, platelet adhesion, and microchannel bed
lifetime are presented as mean values6 standard error.
RESULTS
Surface characterization
Figure 3 displays the water contact angle of the neat PDMS
substrate, plasma-oxidized PDMS substrate, and the PEG-
coated microchannel. Contact angle measurements were
made for up to 10 days following treatment. Unmodiﬁed,
hydrophobic PDMS exhibited a characteristically high con-
tact angle of 105 .21,25 Plasma-oxidation of the PDMS
decreased the hydrophobicity of the surface, as indicated in
the drop of contact angle from 104.4 to 5.2 immediately
after treatment. Within one day after plasma-oxidation,
the resulting PDMS became more hydrophobic (increase in
contact angle from 5.2 to 61.0). Within 5–7 days of
plasma-oxidation, the oxidized surfaces displayed contact
angles comparable to untreated PDMS. In contrast, the PEG-
modiﬁed microchannel surface retains a high level of hydro-
philicity over a period of 10 days, exhibiting a maximum
contact angle of only 27.2 .
The presence of the PEG layer was also conﬁrmed
through XPS analysis of the microchannel (Fig. 4). Survey
scans of neat PDMS and PEG-coated PDMS highlight the
changes in elemental composition after PEG grafting, namely
the increase in carbon and oxygen content and correspond-
ing decrease in silicon. A high-resolution scan of the C1s
binding energy depicted the CASi bond peak of PDMS at
284.4 eV on both samples. However, the dual peak signal of
the PEG sample included the presence of the characteristic
CAO bond25 at 286.5 eV,41 not found on unmodiﬁed PDMS.
Protein adsorption to PEG-coated microchannels
In addition to general material characterizations, coated
microchannels were evaluated in terms of their functionality
when exposed to biological ﬂuids. Fluorescently-labeled
ﬁbrinogen at physiologically relevant concentrations was
ﬂowed through single microchannel structures for one hour
at 37C (Fig. 5). This experiment was performed on PEG-
coated microchannels ranging from 0 to 28 days old in
order to draw conclusions about the stability and efﬁcacy of
the coating after periods of storage in an ambient environ-
ment. The PEG-coated microchannels showed signiﬁcantly
reduced adsorption for both protein concentrations as com-
pared to uncoated controls at all time points. To determine
whether adsorption would increase after a longer protein
exposure time, the experiment was repeated at time point 0
for a duration of 8 h [Fig. 5(A), open symbols]. It was found
that the resulting adsorption levels on either uncoated or
PEG-coated channels did not signiﬁcantly change from the 1
h experiment. Most importantly, there is no statistical differ-
ence in the protein adsorption levels within the PEG group
for either concentration.
Platelet adhesion to PEG-coated microchannels
Freshly coated single microchannels were also exposed to
human PRP to investigate the extent of platelet adhesion to
the coated surfaces. After 30 min of exposure to PRP ﬂow,
ﬂuorescent images were taken of the channel surfaces and
the area covered by platelets was measured (Fig. 6). PEG-
coated channels exhibited nearly undetectable levels of pla-
telet adhesion. In comparison to uncoated PDMS, PEG-
coated microchannels decreased platelet adhesion by more
than 50-fold.
A similar difference was seen in the SEM images of
whole blood-exposed microchannels (Fig. 7). Extensive pla-
telet adhesion as well as protein adsorption is seen on
uncoated microchannel surfaces, while very little of either is
visible on PEG-coated channels. Morphological differences
between the platelets on each surface are also apparent,
with platelets on the uncoated material appearing branched
and in an activated state [Fig. 7(C)] as compared to the
round, unactivated platelets on the PEG surface [Fig. 7(D)].
FIGURE 3. Water contact angle on unmodified PDMS (), plasma-
oxidized PDMS (~), and PEG-grafted microchannel surfaces (). Data
are the mean6 std. error (n54).
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Long-term thrombogenic response in complex
microchannel networks
The trans-device pressure drop of both PEG-coated and
uncoated microchannel networks was measured over time
while ﬂowing whole heparinized blood through the devices
[Fig. 8(A)]. The average time until the initial pressure
doubled for each experimental group is displayed in Figure
8(B), with the PEG-coated microchannel networks exhibiting
a lifetime of more than 163 longer than uncoated controls.
Figure 9(A) is a representative image of a microchannel net-
work ﬁlled with blood during the ﬂow experiment. Figure
9(B) contains representative macroscopic and microscopic
images of residual clotting within the PEG-coated and




Oxygen plasma treatment. Previous studies investigating
oxygen plasma treatment of PDMS have documented the
hydrophobic recovery of the oxidized surface, resulting in
the rapid degradation of functional groups and hydrophilic
character.21,44 In contrast, the stability of our PEG surface’s
contact angle over time is an indication of the grafted
molecular layer formed during the coating reaction. It is
believed that this is because a large PEG chain is able to
sterically and electrostatically resist rearrangement into the
PDMS bulk as well as bond degradation in ambient storage.
The observed stability also suggests that the coating may
remain functional for an extended period of time after
application, as hydrophilicity plays a major role in biomate-
rial hemocompatibility.18,19
PEG grafting. Following plasma activation, PEG-silane mole-
cules can react with and graft to the PDMS surface. Because
of the transient nature of plasma-generated reactive sites on
PDMS, procedure timing, PEG chain length, solute concentra-
tion, and zero ﬂow during reaction were determined to be
key parameters in generating an effective and stable surface
coating. Anhydrous acetone was speciﬁcally chosen as a sol-
vent for the coating solution due to its low tendency to
swell the PDMS substrate as compared with other organic
solvents.45 Furthermore, acetone will not react with the
functional methoxy-silane groups on the PEG chain needed
for the silanization reaction. Dilution in a solvent is also
important as it allows for the increased mobility of PEG
molecules in solution, leading to increased interaction with
the reactive hydroxyl groups on the PDMS surface.
Other studies have used similar approaches to PDMS
modiﬁcation, although they were performed on planar mate-
rial samples as opposed to a microchannel model.23,27,31,37
Coating processes developed in this way may not translate
well to microﬂuidic structures due to the harsh assembly
conditions of most PDMS microﬂuidic devices.32 Any preap-
plied molecules would likely be cleaved, altered, or inacti-
vated by oxygen radicals by plasma exposure during device
bonding. To solve this problem, our work uses the same
plasma activation step to achieve PDMS bonding and activa-
tion of the material surface for PEG grafting. PEG functional-
ization is performed immediately after PDMS bonding on a
FIGURE 4. XPS spectra of unmodified (A) and PEG-grafted (B) PDMS surfaces. High resolution scans (right insets) of the C1s signal highlight the
presence of the CAO bond within the grafted PEG chain.
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fully assembled device. In our studies, the timing of this step
was discovered to be crucial to coating integrity. Process
optimization revealed that the PEG solution must be intro-
duced into the channel within 45 s to 1 min of removal from
the plasma system. As time elapses after plasma treatment,
hydroxyl bonding sites disappear due to the hydrophobic
recovery of PDMS. This phenomenon is largely due to mobile
oligomer chains from the PDMS bulk migrating to the surface,
decreasing hydrophilic character and increasing the contact
angle back to near that of untreated silicone.21,22 It was
observed that excessive hydrophobic recovery results in
fewer PEG chains bonding to the surface, a higher initial con-
tact angle, and more rapid degradation of the coating during
storage. In addition to coating application issues, the func-
tionality of previous studies planar samples may not be rep-
resentative of a coating’s performance under shear stress and
within an enclosed microﬂuidic geometry.46,47
Within the realm of microﬂuidic modiﬁcation, much past
work has been focused on applications outside of blood-
contacting biomaterials and hemocompatibility.24–26,33,34
Studies that have looked at blood-material interactions have
used nonsilanized coating methods,36 utilized a planar test-
ing model as described above,48 or have not investigated
the degradation of their coating over time.37 One recent
study does describe the coating and thrombogenic evalua-
tion of an intact microchannel, but is limited to a relatively
large channel height (350 lm) and short-term blood expo-
sure (1 h).14 Our work seeks to provide a platform for dura-
ble microﬂuidic surface modiﬁcation and physiologically
relevant evaluation, namely applying a silanized PEG coating
to complex assembled microchannel structures and investi-
gating the long-term hemocompatibility of that coating
within the microchannel geometry.
Hemocompatibility assessment
Protein and platelet interactions. The physical scale of
microﬂuidic devices lends them directly to applications that
mimic or interact with the function of human capillary beds,
often necessitating high hemocompatibility. Thus, our pro-
tein adsorption and platelet adhesion experiments were
designed to mimic physiologic conditions of microscale pul-
monary vascular ﬂow. Fibrinogen was chosen as the protein
of interest due to its key role in the intrinsic coagulation
cascade and relative abundance in human plasma.49,50 PEG-
coated microchannels exhibited drastically decreased ﬁbri-
nogen adsorption at physiologic temperature, concentration
(2 mg/mL) and shear stress (5 dynes/cm2).43 It was
also notable that protein adsorption levels did not signiﬁ-
cantly change at any time point of channel aging, revealing
that our coating process is capable of producing protein
resistant surfaces with a “shelf life” of at least several
weeks. Overall, this resistance to ﬁbrinogen adsorption is
important to long-term hemocompatibility, as surfaces
which adhere low levels of ﬁbrinogen have been shown to
reduce the coagulation response of blood.51,52
We have previously shown that PEG-grafted substrates
with reduced protein adsorption also prevent subsequent
cell adhesion.53,54 Therefore, we also examined the ability of
our PEG-grafted microchannels to resist platelet adhesion.
As anticipated, a signiﬁcant reduction in platelet adhesion
FIGURE 5. Fibrinogen adsorption from 2.0 mg/mL (A) and 0.5 mg/mL
(B) solutions to uncoated PDMS () and PEG-coated () microchannel
surfaces following 1 h of protein exposure. An 8 h experiment was
also performed at the 0 day time point, highlighted in (A,  and ).
Data are the mean6 std. error (n5 3). *p< 0.05.
FIGURE 6. Fluorescent platelet adhesion to microchannel surfaces. Data
are the mean6 std. error (n5 3). *p< 0.05. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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was seen on PEG-coated channel surfaces, as compared to
unmodiﬁed PDMS microchannels. For platelet adhesion
experiments, a ﬂow rate of 0.7 mL/min was again used to
mimic physiological shear stress. The observed lack of plate-
let adhesion presents further evidence of improved blood
compatibility on our PEG-coated channels (Fig. 6). It has
been suggested that small platelet aggregates form the ini-
tial precursors of a larger-scale clotting response.51
SEM images of surface adhered platelets reveal addi-
tional differences between the two surfaces. High-
magniﬁcation images show platelets adhered to uncoated
surfaces to be spread out and branching [Fig. 7(C)], as com-
pared to the typical rounded shape seen on PEG samples
[Fig. 7(D)]. The branched appearance is indicative of acti-
vated platelets, which act to bind additional platelets and
release pro-coagulatory factors, continuing the coagulation
cascade on a biomaterial surface.51 Thus, we see that not
only does the PEG-coated microchannel adhere far fewer
cells, but that they are not bound in a pro-coagulatory state.
Because of the use of whole blood in the SEM experiment,
we also see evidence of signiﬁcant protein adsorption and
ﬁbrin formation [Fig. 7(A)] in addition to platelet adhesion
and activation on the uncoated microchannel surface. This
combination of events, resulting in surface-bound clotting, is
not apparent on the relatively pristine PEG channel [Fig.
7(B)]. Viewed together, these results demonstrate that our
coating method is capable of producing highly hemocompat-
ible microchannel surfaces that remain functional over a
period of weeks.
Long-term blood ﬂow and coagulation in complex
geometries. Following the initial protein and platelet testing
in single microchannel devices, the coating was applied to a
more complex microﬂuidic system consisting of thousands
FIGURE 7. Representative SEM images of platelets adhered to unmodified (A, C) and PEG-coated (B, D) microchannel surfaces. Arrows in A and
C identify activated platelets. Images A and B at 25003 magnification, C and D at 20,0003.
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of branching microchannels of varying dimensions. This
model allowed us to more rigorously test the coating’s abil-
ity to resist blood coagulation by using a ﬂow path includ-
ing dimension changes, potential areas of stasis and
turbulent ﬂow, and channel heights on the scale of capilla-
ries and red blood cells (20 lm).
At a ﬁxed blood ﬂow rate, the pressure drop across a
microchannel bed correlates directly with the ﬂuidic resist-
ance of the microchannels. In our system of unchanging
PDMS channel dimensions and area, increases in resistance
(pressure values) were attributed to coagulation and throm-
bosis within the microchannels.14
As expected from protein and platelet adhesion results,
PEG-coated microchannel beds displayed high hemocompati-
bility and a drastically increased lifetime under whole blood
ﬂow as compared to uncoated controls (Fig. 8). Despite
being exposed to blood ﬂow for 19 h compared to 45 min
for the control, a PEG-coated channel bed retained many
fewer surface-bound clots after washing [Fig. 9(B), top].
Microscopic images were also taken of the smallest micro-
channels in areas where no clots were visible to the naked
eye [Fig. 9(B), lower insets]. Surface-adhered platelets and
red blood cells can be clearly seen in the uncoated channels,
while PEG-coated channels remain clear even after 253 lon-
ger blood exposure than the uncoated control. Despite the
use of heparin to slow the coagulatory response, signiﬁcant
clotting in less than 1 h was seen in uncoated devices. This
highlights the need for the PEG coating, especially in appli-
cations necessitating periods of longer use. A similar differ-
ence in comparative biological response was seen in the
platelet adhesion experiment (Fig. 6), which used sodium
citrate as a short-term anticoagulant, suggesting that in this
model the type of anticoagulant used does not have a signif-
icant impact on the relative blood response between
uncoated and PEG-coated microchannel surfaces.
In addition to delaying the intrinsic coagulatory
response, the hydrophilic PEG coating appeared to decrease
the initial pressure drop of the microchannel beds, although
the difference was not statistically signiﬁcant. However, in
all experiments, the initial pressure for the PEG-coated bed
(avg.6 std. dev. of 15.26 7.2 mmHg) was lower than that of
the uncoated control (44.66 29.8 mmHg). It is believed that
the lack of signiﬁcance due to the large variation stems
from characteristic differences between the blood samples
such as hematocrit.
FIGURE 8. (A) Representative plot of microchannel bed pressure drop
over time for uncoated PDMS () and PEG-coated (2) beds. (B) Aver-
age lifetime for uncoated vs. PEG-coated beds. Data are the
mean6 std. error (n54). *p< 0.05.
FIGURE 9. (A) Example blood-filled microchannel bed during experi-
ment. (B, top) Representative post-wash images of uncoated and
PEG-coated microchannel beds and (B, lower insets) 103 microscopic
images of the smallest microchannels. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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It is interesting to note that when the PEG-coated micro-
channel beds were left under blood ﬂow overnight after 7
h, stirring of the blood reservoirs was stopped. It was dur-
ing this time period that the majority of the pressure
increase was seen [Fig. 8(A)]. It is possible that at least
some of this pressure increase is due to an increase in rela-
tive blood viscosity as opposed to microchannel coagulation,
as the cellular component of the blood separates to the bot-
tom of the reservoir over time. Future experiments will
incorporate automatic gentle agitation of the blood reser-
voirs to ensure a constant viscosity.
These results present the strongest evidence of our PEG
coating’s ability to improve the hemocompatibility of PDMS
microchannels, particularly in a complex microﬂuidic device
and over a long period of blood exposure.
Relevance to microﬂuidic devices. Hemocompatibility is
crucial for microdevices in blood-contacting applications, as
it delays the intrinsic coagulation response and allows for
prolonged, unobstructed ﬂow through the device channels.
Coated devices will therefore have increased functional life-
times and thromboembolism will be less of a risk during in
vivo device use. Because of the simplicity of the coating
application, we believe that this platform is immediately
applicable to a wide range of PDMS microﬂuidic devices.
Speciﬁcally, our group will be applying the coating to a
microﬂuidic artiﬁcial lung,10 aiming to extend the functional
lifetime of the device. Other applications where improved
long-term hemocompatibility may be desirable include
microﬂuidic kidneys,55 synthetic vasculature,56 and blood
separation devices.57
The reaction process is rapid, uses common and inex-
pensive reagents, and occurs at room temperature, allowing
for coatings to be applied with minimal additional equip-
ment or training. Also, because the method utilizes a simple
silanization reaction, stable surfaces can be produced using
any coating molecules with a terminal methoxy-silane
group. Thus, microchannels could be easily custom-coated
with any number of silane-functional compounds, such as
proteins, charged groups, bioactive molecules, or other poly-
mer chemistries. The long term shelf life of the applied coat-
ing also allows for devices to be fabricated well in advance
of their intended use and stored until needed without sacri-
ﬁcing functionality. Using the same plasma activation step
for both PDMS bonding and coating formation may be a
drawback to devices which require multiple steps during
assembly. However, this strategy is well suited for use with
most current microﬂuidic designs, and with modiﬁcation
may be successfully applied to more complex structures.
CONCLUSIONS
In this work, we have developed a method to apply a silan-
ized PEG coating to intact microchannel structures after
assembly. The long-term stability of the coating was charac-
terized for aging periods of up to 28 days, demonstrating an
extended shelf life of coated structures. The ability of the
channels to resist ﬁbrinogen adsorption under physiologic
conditions was investigated as well as platelet adhesion
from human blood. Finally, the coating demonstrated a sig-
niﬁcant hemocompatibility improvement in complex micro-
ﬂuidic devices, increasing the lifetime of coated
microchannel networks to more than 11 h under whole
blood ﬂow, 163 longer than controls. It is envisioned that
this approach can be used as a coating platform for other
microﬂuidic applications to ensure long-term hydrophilicity
or hemocompatibility.
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